Industry news

• Anti-vaccine sentiment causing deaths, subjecting women to cervical cancer, expert says

  03 December 2018 Eric Sagonowsky / FiercePharma

  In recent years, the anti-vaccine movement has gained steam and attracted a growing number of headlines. Now, a vaccine expert says the movement is starting to result in its first deaths. 

• Brexit ‘could be an opportunity for U.K. clinical research’

  03 December 2018 Phil Taylor / FiercePharma

  The U.K. has been punching below its weight in attracting clinical research, and Brexit could provide an opportunity to remedy that, according to an industry body. The Association of Clinical Research Organizations (ACRO) recently sent a series of recommendations to Lord O’Shaughnessy, Parliamentary Under Secretary of State for Health, with six policy recommendations that it thinks could elevate the country into the top tier of clinical research locations.

• FAS Russia suggests to optimize the medical equipment market

  30 November 2018 GMP News

  On 26 November 2018, the working group on Competition and Regulation of OECD Competition Committee held a Round Table on “Developing State-Financed Healthcare Market”. The Organisation for Economic Co-operation and Development (OECD) is an intergovernmental economic organisation with 36 member countries created to promote policies that will improve the economic and social well-being of people around the world.

• Online health info seekers struggle with overload and trust: study

  30 November 2018 Beth Snyder Bulik / FiercePharma

  Weber Shandwick’s recent “Great American Search for Healthcare Information” study in some ways ended up being the great American search for trust. The communications and marketing services company, along with partner KRC Research, found in general a sizable credibility gap between what healthcare information seekers find online and what they trust.

• Pharma market penetration of Russian drugs rose in the 1st half of 2018

  29 November 2018 GMP News

  Russian drugs penetration into the key segments of the pharmaceutical market rose in the 1st half of 2018. This was presented to the participants of the VII Annual Forum of chief financial officers in the pharmaceutical business, “Pharma CFO 2018”, by Raziya Solodova, the Deputy Head of Economics and Pharmaceutical & Medical Industry Analysis Department of FSI “SID&GP”.

• Scientists created a temperature-stable polio vaccine

  29 November 2018 GMP News

  Researchers from The Keck School of Medicine of the University of Southern California (USA) have developed a polio vaccine that doesn’t require refrigeration. The vaccine, which was freeze-dried into a powder, kept at room temperature for four weeks and then rehydrated, offered full protection against the polio virus when tested in mice. The study itself appeared appears in the journal mBio.

• On a roll with FDA approvals, Pfizer doubles down in AML with Daurismo nod

  28 November 2018 Carly Helfand / FiercePharma

  Make that four drug approvals for Pfizer’s oncology unit in less than two months. In a welcome streak for the pharma giant—what with Lyrica generics looming—the FDA handed out a go-ahead for Daurismo, a treatment for acute myeloid leukemia. The new approval puts Daurismo, in tandem with low-dose cytarabine chemo, in line to treat newly diagnosed adults aged 75 and older or those for whom intensive induction chemo isn’t an option.

• Treatments for Tomorrow and a Vision for the Future: A Look at Innovation

  28 November 2018 FiercePharma

  In 1928, scientists at Eli Lilly and Company in collaboration with academic investigators developed a liver extract-product that could be used to treat pernicious  anemia , a life-threatening blood disorder. This innovative treatment led to a standard of therapy for pernicious  anemia  and its importance was recognized with the Nobel Prize for Medicine in 1934. Lilly’s scientists worked with all available technology and resources and with external collaborators to solve an unmet need for people living with this condition.

• Big Data and AI provide better diagnosis and treatment

  27 November 2018 European Pharmaceutical Review

  MedUni Vienna researchers have developed a way to use retinal imaging to diagnose diabetes, explaining how the technique could be used for other conditions… MedUni Vienna’s Department of Ophthalmology and Optometrics has revealed its progress in using digital retinal screening to diagnose patients with diabetes.

• Trends for pharma in 2019? Stressed docs, data drivers, price populism and more, says Syneos Health

  27 November 2018 Beth Snyder Bulik / FiercePharma

  With 2018 almost in the bag, it’s time to look to the pharma trends percolating for 2019. Back for another gander into the crystal ball is Syneos Health, formerly InVentiv Health pre-merger with INC Research, with its latest annual prognosticating report due out Tuesday.